# GS-6207 vs Canonical RT drugs

|GS-6207|RT|Evidence in Paper|
|---|---|---|
|Large Therapeutic Window|More cytotoxicity|$CC_{50}$|
|Trivial Cross Resisitance|Cross Resistance|*GS-6207 exhibits antiviral activity at picomolar concentrations against all subtypes of HIV-1 that we tested, and shows high synergy and no cross-resistance with approved antiretroviral drugs.*|
